Phase 3 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older at the time of signing the consent form
- You have been diagnosed with Stage II or Stage III triple negative breast cancer (a specific type of breast cancer defined by certain lab test results on the tumor)
- After your surgery and/or chemotherapy, a blood test called ctDNA still shows signs of cancer material in your blood
- You are generally well enough to carry out light activity or self-care (confirm with trial site)
- If recommended by your doctor, you are willing to receive radiation therapy following your hospital's guidelines
- You have received or are receiving chemotherapy after surgery, following standard treatment guidelines
- There is tumor tissue available from your surgery that can be used for a type of detailed genetic testing called next generation sequencing
- You agree to give blood samples every 3 months for 5 years to monitor for cancer signals in the blood
Who may not be able to join:
- You have previously received a type of cancer treatment that targets the PD-1 or PD-L1 immune pathways
- You are currently pregnant, breastfeeding, or planning to become pregnant or breastfeed during the trial
- Your breast cancer has already spread to distant parts of the body beyond nearby lymph nodes (Stage IV)
- You are currently taking part in another clinical trial that involves a treatment intervention
- You have or have had another serious cancer, and treatment for it finished less than 3 years ago
- You have an autoimmune disease (where the immune system attacks the body) that would prevent you from safely taking the study drug camrelizumab (confirm with trial site)
- You have another serious or uncontrolled health condition that your doctor believes would make it unsafe or unsuitable for you to take part
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Invasive Disease Free Survival(IDFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.